Revenue: The sum of all revenue fields included for a company's operating activities.
VistaGen Therapeutics, Inc. (VTGN) had Revenue of $-0.01M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$-0.01M |
$-13.63M |
|
-- |
|
$-0.01M |
|
$14.48M |
|
$-14.49M |
|
$0.86M |
|
$-13.63M |
|
$-13.63M |
|
$-13.62M |
|
$-13.62M |
|
$-13.63M |
|
$-13.62M |
|
$-14.49M |
|
$-14.58M |
|
30.88M |
|
30.88M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$82.08M |
|
$0.48M |
|
$2.27M |
|
$84.34M |
|
$12.61M |
|
-- |
|
$1.34M |
|
$13.95M |
|
$70.39M |
|
$70.39M |
|
$70.39M |
|
29.00M |
|
| Cash Flow Statement Financials | |
$-42.10M |
|
$-13.15M |
|
$3.21M |
|
$119.17M |
|
$67.13M |
|
$-52.03M |
|
$4.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
96633.38% |
|
96633.37% |
|
-- |
|
90900.03% |
|
90900.03% |
|
$-42.29M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-- |
|
-- |
|
-19.35% |
|
-19.35% |
|
-16.15% |
|
-19.35% |
|
$2.43 |
|
$-1.37 |
|
$-1.36 |
|